Recommended Risk Stratification Strategy For Osteoporosis Therapy

recommended risk stratification strategy for osteoporosis therapy

Low/Moderate-risk patients
- Oral bisphosphonates (alendronate, risedronate, ibandronate)
- Zoledronic acid
- Denosumab
High-risk patients ^aa High-risk patients: old age, prior fracture, very low BMD (T-score <–3), high fall risk, GC use.
- Zoledronic acid
- Denosumab
- Teriparatide
- Abaloparatide

Major risk factors for the development of osteoporosis
What are the major risk factors for the development of osteoporosis NonmodifiableModifiableAdvanced ageLow calcium intakeRace…
When should pharmacologic therapy be initiated for osteoporosis
When should pharmacologic therapy be initiated for osteoporosis? Pharmacologic therapy should be advised for patients…
Nonpharmacologic therapies for osteoporosis
Nonpharmacologic therapies for osteoporosis What nonpharmacologic therapies are available for patients with osteoporosis? When should…
What is osteoporosis
What is osteoporosis? Osteoporosis is a skeletal disorder characterized by compromised bone strength, which predisposes…